Individuals heterozygous or homozygous for the variant aldehyde dehydrogenase (ALDH2) allele (ALDH2 *2), which encodes a protein differing only at residue 487 from the normal protein, have decreased ALDH2 activity in liver extracts and experience cutaneous flushing when they drink alcohol. The mechanism by which this allele exerts its dominant effect is unknown. To study this effect, the human ALDH2 *1 cDNA was cloned and the ALDH2 *2 allele was generated by site-directed mutagenesis. These cDNAs were transduced using retroviral vectors into HeLa and CV1 cells, which do not express ALDH2. The normal allele directed synthesis of immunoreactive ALDH2 protein (AL-DH2E) with the expected isoelectric point. Extracts of these cells contained increased aldehyde dehydrogenase activity with low Km for the aldehyde substrate. The ALDH2 *2 allele directed synthesis of mRNA and immunoreactive protein (ALDH2K), but the protein lacked enzymatic activity. When ALDH2 *-expressing cells were transduced with ALDH2 *2 vectors, both mRNAs were expressed and immunoreactive proteins with isoelectric points ranging between those of ALDH2E and ALDH2K were present, indicating that the subunits formed heteromers. ALDH2 activity in these cells was reduced below that of the parental ALDH2 *l-expressing cells. Thus, the ALDH2 *2 allele is sufficient to cause ALDH2 deficiency in vitro. (J. Clin. Invest.
Introduction
As many as 50% of Asians flush when they drink alcohol. This phenotype is usually associated with deficiency in the activity of the mitochondrial aldehyde dehydrogenase (ALDH2)' (1) , a tetrameric NAD + -dependent enzyme. This enzyme is responsible for maintaining low concentrations of acetaldehyde in the liver during ethanol oxidation (2, 3) . It has a very low Km for acetaldehyde and other short chain aldehydes (-1 pM) and high catalytic efficiency. Activity and gel electrophoretic assays demonstrating the deficiency have been carried out using hair root (1, 4, 5) and liver biopsy specimens (6) derived from individuals with the flush reaction. To determine the explanation for the deficiency, the enzyme was purified from liver deficient in ALDH2 activity. The inactive enzyme was found to differ from the active enzyme at residue 487, the result of a glutamate to lysine substitution (7, 8) . The allele encoding the active enzyme was named ALDH2 *1 and the inactive variant ALDH2 *2, and the corresponding protein subunits have been named ALDH2E and ALDH2K, respectively. These genes have been expressed in E. coli. The ALDH2K enzyme had markedly altered kinetic properties, with a 150-fold increase in Km for NAD+ and a 2-10-fold reduction in Vma,, compared with the normal enzyme (9) .
Biochemical studies generally assumed co-dominant inheritance of the ALDH2 deficient phenotype, and predicted that heterozygotes would have half the usual activity of ALDH2 and perhaps suffer from mild flushing, while homozygotes were predicted to have near complete deficiency and severe flushing. However, family studies performed in the early 1980's indicated that alcohol-induced flushing was transmitted in a dominant manner ( 10). After the cloning of the ALDH2 gene ( 11 ) , polymerase chain reaction (PCR)-based genotyping assays demonstrated that the majority of individuals with flushing were heterozygous for the ALDH2 *2 allele (6) . Moreover, ALDH2 deficiency as determined by assays performed on hair roots (4) or liver samples (12) have shown that most ALDH2-deficient samples come from heterozygotes. Quantitation of ALDH activity in liver biopsy samples from individuals genotyped at the ALDH2 locus has indicated that the heterozygotes have perhaps 13% of the normal enzyme activity (6) . Retrospectively, purified enzyme from an ALDH2-deficient liver that was likely to have been heterozygous was reported to contain 15% of the normal low Km ALDH2 activity (13) . When the intensity of flushing has been correlated with genotype, individuals heterozygous for ALDH2 *2 have less severe flushing than the ALDH2 *2 homozygotes (6) . Thus, the ALDH2 *2 allele appears to be incompletely dominant over ALDH2 *1.
The biochemical explanation for the dominant effect of ALDH2 *2 is unknown. Coexpression of the two alleles in bacteria generated enzyme with reduced specific activity (Wang, X.-P., Sheikh, S., and Weiner, H., manuscript in preparation). (12) .
Cloning of human ALDH2 cDNA. The rat ALDH2 cDNA (14) was used to clone a human ALDH2 cDNA from a human liver Xgtl 1 cDNA library. Several overlapping clones were recovered; the largest extended from the codon for asparagine 12 to the polyadenylate tail. Since asparagine 12 is contained in the first exon, the cDNA was extended to fulllength using a PCR strategy. Primers spanning bases -43 to -21 in the 5 '-untranslated region and amino acid residues 6 to 11 were used to amplify this region from human genomic DNA. The PCR product was ligated to the cDNA to generate the full length cDNA. To generate ALDH2 *2 cDNA, the ALDH2 *1 cDNA was subcloned in Bluescript and mutated with an oligonucleotide centered on the codon for residue 487 (5' GCATACACTAAAGTGAAAA 3') using the Amersham in vitro mutagenesis kit. The correct sequence of the ALDH2 *1 cDNA and the mutated allele were confirmed by dideoxy sequencing. The human ALDH2 cDNA was 88% identical to the rat cDNA at the nucleotide level and 95% identical at the amino acid level.
Construction of retroviral vectors. In preliminary experiments, it was found that the cytomegalovirus (CMV) promoter was a stronger promoter in HeLa and CV-1 cells than the SV-40 promoter; therefore, the expression vectors were built from the retroviral plasmid pLNCX (15) . This vector expresses the G418 resistance gene neo driven by the long terminal repeat. The ALDH2 *1 and ALDH2 *2 cDNAs, containing the mitochondrial leader sequences, were cloned into the HindHII site. These plasmids were named pLNCE and pLNCK, denoting vectors for expression of ALDH2E and ALDH2K, respectively. To Isoelectric focusing was performed using 1% agarose gels containing 0.5 ml of pH 3-10 Ampholines, 1.5 ml of pH 4-6 Ampholines, and 20% glycerol in a total volume of 34 ml. The anode and cathode buffers were 0.5 M acetic acid and 0.5 M NaOH, respectively. The gel was prefocused at 5 W for 1 h, then the protein samples were applied and the focusing was continued at 10 W for 2 h. The gel was then stained for enzyme activity in a solution of 10 mM propionaldehyde, 1 mM NAD+, 0.1 mM 4-methylpyrazole, 0.3 mM 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazolium bromide, and 0.14 mM phenazine methosulfate in 50 mM sodium pyrophosphate, pH 8.8. Native ALDH2 was purified from human liver by chromatography of 100,000 g supernatants on DEAE-cellulose and a-cyano-4-hydroxycinnamate-Sepharose affinity columns (20) . This preparation showed a single band of 54,000 molecular weight on SDS-PAGE gels stained with Coomassie blue and was used as a positive control for the isoelectric focusing gels and Western blots.
Western blotting. Proteins fractionated in SDS-PAGE gels or by isoelectric focusing were transferred to nitrocellulose filters by electroelution or capillary blotting, respectively. The filters were blocked with PBS containing 0.1% Tween 20 and 5% BSA, then incubated with polyclonal antiserum raised against purified bovine liver ALDH2. After washing, the filters were developed by incubating them with '25I-labeled After isoelectric focusing and blotting, ALDH2 protein was detected with anti-ALDH2 antibody and "25I-labeled protein A and quantitated by 3-scanning. The standard curves were linear and the antiserum detected the ALDH2E and ALDH2K proteins equivalently in preliminary studies. The amount of ALDH2 protein in the HeLa EK cells was thereby determined relative to the amount in the parental HeLa CE cells.
Results
Transduction and expression of ALDH2 isozyme in vitro. The cloned ALDH2 cDNA had the same sequence as found in the human gene reported by Hsu et al. (11) and was the longest clone yet recovered from a liver library. After verifying that the cloned cDNA and the allele created by site-directed mutagenesis had the expected DNA sequence, the cDNAs representing the ALDH2 *1 and ALDH2 *2 alleles were subcloned into retroviral vectors under the control of the CMV promoter. Amphotropic retroviruses were generated using the packaging cell line PA317. Viral supernatants were used to transduce the cDNAs into HeLa and CV-1 cells. RNA isolated from the cells (Table I ). This activity is consistent with the kinetic properties of ALDH2. On the other hand, cells transduced with the ALDH2 *2 cDNA did not have any higher activity of low Km ALDH than was detectable in the parental cells. The low Km activity was confirmed to be due to the presence of ALDH2 by isoelectric focusing of the extracts and staining for ALDH activity (Fig. 3) . Only the cells transduced with ALDH2 *1 vectors had a band of ALDH activity with the appropriate isoelectric point (-5) .
One possible explanation for the dominant effect of ALDH2K was that it reduced the stability of tetramers con- Fig. 1 EK12, EK13, respectively).
ALDH2E was therefore transduced with the ALDH2K expression virus, and individual clones that were resistant to hygromycin were isolated and tested for expression of ALDH2K mRNA. A Northern blot of RNA from four such clones (denoted by EK2, EK3, EK12, and EK13) is shown in Fig. 4 . The higher molecular weight band represents the ALDH2 *2 mRNA. Relative amounts of the ALDH2 *1 and ALDH2 *2 mRNAs were estimated by /-scanning the filters. The ratio of ALDH2 *2 mRNA to ALDH2 *1 mRNA in the different cell lines ranged from 0.63+0.07 to 1.02+0.14 (n = 5 separate preparations of RNA from each of the cell lines). Thus, these cells provide a model for studying the dominance of ALDH2 *2 over ALDH2 *1. The isoelectric points of ALDH2 protein in cell extracts and extracts of homozygous and heterozygous human livers were determined by isoelectric focusing followed by Western blotting (Fig. 5) . The two homozygous liver samples (lanes I and 3) contained ALDH protein with the expected difference in isoelectric points; the heterozygous liver (lane 2) contained immunoreactive protein that spanned these two pls. The pIs of the retrovirally expressed ALDH2E (lane 4) and ALDH2K (lane 8) were identical to those of the corresponding liver ALDHs. This confirmed that the transduced cells correctly processed the nascent ALDH subunits after mitochondrial import, since the leader peptide is highly basic. In the doubly transduced cells (lanes 5-7), there was the appearance of isozyme forms with pIs intermediate between those of ALDH2E and ALDH2K tetramers, as was seen in the liver samples. Liver and cell extracts were also subjected to isoelectric focusing and staining for ALDH activity (Fig. 6) . The 8). There were faint bands seen migrating slightly cathodal to the major band of ALDH2 activity as had also been seen in the pooled HeLa CE cells (Fig. 3) . Thus, introduction of the ALDH2 *2 expression vector into cells expressing ALDH2 *1 resulted in a reduction of enzyme activity, indicating that the dominant effect of ALDH2 *2 occurred in vitro.
To quantify the dominant effect ofALDH2 *2, enzyme activities of the cell extracts were estimated. The activity of the extracts from each doubly transduced cell line was lower than that of the ALDH2 *I-expressing cell line from which they were derived, ranging from 22-43% (mean 34%) of that activity (ALDH2E-expressing cells, 22.3±0.07; ALDH2E and -K co-~~~~~0~~~ ( 1 2 3 4 5 6 7 8 Figure 6. Expression of ALDH2 activity in liver and in doubly transduced HeLa cell lines. The same samples shown in Fig. 5 were analyzed by isoelectric focusing with staining of the gels for ALDH activity using propionaldehyde and NAD + as substrates. The more cathodal band seen in lanes 1-3, containing liver extracts, represents ALDH1 activity. Enzyme activity was visualized at the p1 of the ALDH2E tetramers (compare with lane 1), despite the fact that much ALDH2 protein from the doubly transduced cells was distributed more cathodally (compare Fig. 5 (Fig. 7 A) to determine if there was a relationship between the amount of ALDH2K subunit expressed and the ALDH2 activity. As the relative amount of ALDH2 *2 mRNA increased, ALDH2 activity fell progressively.
Although these experiments were designed with the intent that the doubly transduced cells would express the same amount of ALDH2E as the parental cell line, an additional confounding variable was the apparent difference in the absolute amount of ALDH2 *1 mRNA in the different cell lines (Fig. 4) . To control for this variation we estimated the amount of immunoreactive ALDH2 protein (representing the sum of ALDH2E and ALDH2K proteins) present in the cells by quantitative Western blotting. The amount of ALDH2 protein in the doubly transduced cell lines ranged from 1.2-to 2.1-fold greater than that in the HeLa CE cells, and the amount of the active ALDH2E subunit (calculated by multiplying relative protein level by the relative amount of ALDH2 *1 mRNA) was in some cases lower than that in the parent cells. When the calculated amount of ALDH2E protein was taken into account, the activities expected in the absence of a dominant effect of ALDH2K were 18.1, 16.3, 23.0, and 16.1 nmol/min per mg protein, for EK2, EK3, EK12, and EK13 cells, respectively. The observed activities (given above) were 39, 52, 22, and 60% of the expected activities. From a least-squares fit of these data it was possible to estimate that cells expressing equal amounts of ALDH2 *1 and ALDH2 *2 mRNAs (i.e., in heterozygous liver cells) would express 31% of the predicted ALDH2 activity (not shown).
Discussion
This study examined the mechanism by which the ALDH2 *2 allele causes the dominantly inherited ALDH2 deficient phenotype. Previous work with bacterial expression systems indicated that the ALDH2 *2 allele could direct the synthesis of an enzyme with markedly impaired catalytic function (9), but such systems do not test the ability of the expressed protein to enter and be assembled in the mitochondrial matrix space. We chose to express the two ALDH2 alleles in tissue culture cells that lacked endogenous ALDH2 mRNA and protein, and thus had virtually no background signals. Retroviral vectors were utilized because of the efficiency of transduction and high levels of expression of the cDNAs compared with results we had obtained with other expression systems. Initially, pools of HeLa and CV-1 cells transduced with only one of the expression vectors were characterized to test this approach. The results obtained suggest that this system represents a good model to study the interaction between ALDH2 *1 and ALDH2 *2. The molecular weights and pIs of the enzymes expressed in the HeLa cells were the same as those detected in the human liver samples, consistent with the removal of the mitochondrial leader. Thus, the subunits were very likely to have been properly transported into the mitochondria and processed. Activity measurements documented that the ALDH2 *1 allele directed the synthesis of a catalytically active enzyme with low Km for the aldehyde substrate, whereas the ALDH2 *2-encoded protein expressed in these cells was not active in the enzyme assay used. However, this assay would not have detected ALDH2K activity if its kinetic properties were the same as those of the bacterially expressed ALDH2K (9) because the NAD+ concentration was not high enough. The inability to visualize the ALDH2K form on isoelectric focusing gels stained for activity has also been reported for the bacterially synthesized enzyme (9) .
In the HeLa cells initially transduced with each of the vectors, pools of ALDH2E-and ALDH2K-producing cells expressed similiar levels of mRNA and ALDH2 protein, suggesting that the two isozymes had similar stability. The normal and variant proteins also had similar apparent half-lives as determined in protein decay experiments, indicating that the ALDH2 *2 allele does not encode an overtly unstable protein.
Additional pulse-chase experiments would be needed to deter- (22) , but had not previously been directly demonstrated. Furthermore, introduction of ALDH2 *2 into cells expressing ALDH2 *1 resulted in a decrease in the low Km ALDH activity of those cells. Staining of the isoelectric focusing gels for ALDH activity showed that the most active form was found at the most anodal isoelectric point (similar or identical to that of the (ALDH2E)4 tetramer). The fainter activity bands migrating cathodal to the major band probably represent posttranslationally modified enzyme (generated by proteolysis or oxidation of sulfhydryl groups) since it was also seen in the cells expressing only the ALDH2E subunit. If only the (ALDH2E)4 tetramer were active in the heterozygous cells, this would suggest that incorporation of a single mutant subunit inactivated the tetramer, as had been speculated in the past (9, 12) .
However, the activity assays were not consistent with this model. If the heterozygous cells produced equal amounts of the ALDH2 subunits that assembled into tetramers randomly, the abundance of the various combinations of subunits should obey a binomial distribution (Table II) . ALDH2 tetramers have been shown to exhibit half of the sites reactivity (24, 25) , although the location of the active sites within the quaternary structure is not known. Thus, a cell synthesizing n ALDH2E subunits (for example, the HeLa CE cells) will have n/4 tetramers, containing n/2 active sites. It is possible that in the heterotetramers, two ALDH2E subunits are required to create an active site; practically speaking we can ignore any low activity contributed by the ALDH2K subunits. Table II shows calculations of the average numbers of active sites among the heterotetramers, given various assumptions about the number of active sites per tetramer and the distribution of the different combinations. The predicted ALDH2 activity in the cells was then calculated by multiplying the average number of active sites per tetramer by the number of tetramers present. In cells expressing the two alleles equally, the number of subunits synthesized is 2n, and thus the number of tetramers is 2n/4 or n/2. If the ALDH2K subunits do not interfere with the ALDH2E subunits and the E3K enzyme can form two active sites (model 1), the activity is n/2, or 100% of that calculated for the cells expressing only ALDH2E subunits. We found reduced ALDH2 activity in the doubly transduced cells, and thus there must be some interference by the ALDH2K subunits. In these models, interference was defined as fewer active sites formed in the E2K2 or E3K enzymes. We estimated that heterozygous cells would express 31% of the predicted activity of ALDH2. Model 3, which predicts 37% of the activity of the parental line, agrees most closely with the experimental findings. Since the cell lines deviated from the assumptions of the model in that they did not express the same amount of ALDH2 *1 and ALDH2 *2 mRNA, we also calculated the enzyme activity expected for each model with varying ratios of ALDH2E and ALDH2K subunits and plotted these activities with the relative activity of the double transduced HeLa cell lines (Fig. 7 B) . The relative activities found in the cell lines were closest to those predicted by model 3.
The activity predicted to be expressed in liver using these models would be reduced by half, because the acquisition of an ALDH2 *2 allele is accompanied by the loss of one of the ALDH2 *1 alleles, with a reduction in the total number of AL-DH2E subunits synthesized. For example, using the model proposed for the cells, ALDH2 *1 homozygotes would synthesize 2n of the ALDH2E subunits, forming 2n/4 or n/2 tetramers, with two active sites each, or n active sites, twice that of model 1 in the cells. Thus, model 3 predicts 18% residual activity in heterozygous human livers. Two reports of residual ALDH2 activity in ALDH2-deficient livers found 13% (6) and 15% (13) of the normal activity, compatible with the model. However, these studies were performed without the knowledge of additional ALDH isozymes, and may not be definitive. It is not known why residual ALDH activity was visualized on electrophoretic gels for the doubly transduced cells but not in the heterozygous liver sample. Perhaps slightly greater expression of ALDH2E than ALDH2K subunits in the cells (see Fig. 5 ) resulted in the formation of more of the active ALDH2 tetramers than occurs in heterozygous livers. Alternatively, although the half-lives of subunits appeared similar in the HeLa cells, they may differ in hepatocytes.
It is not clear why the activity suggested to be associated with the E3K enzyme was not readily visualized as a distinct band on gels stained for ALDH activity. Experience with the bacterially synthesized ALDH2K enzyme suggests that, for unknown reasons, it does not stain as expected on gels (9) . It is possible that the heterotetramers do not behave electrophoretically as the mean of the individual subunits. This was suggested by the appearance of the immunoblot of the isoelectric focusing gels. We did not observe discrete bands of differing pI between the locations of the ALDH2E and ALDH2K forms, nor has this been observed with the bacterially synthesized heteromers. This could be explained by subtle differences in the electrophoretic behavior of heterotetramers if subunit interactions are not all equivalent, or by different affinities of the subunits for NAD', leading to differences in net charge among subpopulations of the protein that could not be resolved by the isoelectric focusing system used here. Posttranslational modifications that alter the isoelectric points could also have occurred. Complete understanding of the dominant effect of ALDH2 *2 awaits the isolation and kinetic characterization of the individual ALDH2 heterotetramers.
